Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The biological basis of disease recurrence in psoriasis: a historical perspective and current models
L. Puig, Antonio Costanzo, Ernesto J. Muñoz‐Elías, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 5, pp. 773-781
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 116
Triggers for the onset and recurrence of psoriasis: a review and update
Suwen Liu, M. L. He, Jian Jiang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade
Luc Francis, Daniel McCluskey, Clarisse Gânier, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy
James G. Krueger, Kilian Eyerich, Vijay K. Kuchroo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature
Bárbara Lobão, Diana Lourenço, Ana Giga, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 10
Psoriasis as a systemic disease
Ulrich Mrowietz, Felix Lauffer, Wiebke Sondermann, et al.
Deutsches Ärzteblatt international (2024)
Closed Access | Times Cited: 8
Residual non-specific and disease-specific inflammatory markers in successfully treated young psoriasis patients: a cross-sectional study
Eva Klara Merzel Šabović, Tadeja Kraner Šumenjak, Mojca Božič Mijovski, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Open Access | Times Cited: 1
Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases
Yiqiao Chen, C.E.M. Griffiths, Silvia Bulfone‐Paus
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1564-1564
Open Access | Times Cited: 18
Integrated network pharmacological analysis revealed that Smilax glabra Roxb. alleviates IMQ-induced psoriatic skin inflammation through regulating T cell immune response
Yingxue Guo, Weiye Mao, Ningning Bai, et al.
Journal of Ethnopharmacology (2024) Vol. 325, pp. 117836-117836
Closed Access | Times Cited: 6
Characteristics and sources of tissue-resident memory T cells in psoriasis relapse
Canbin Dong, Lanmei Lin, Juan Du
Current Research in Immunology (2023) Vol. 4, pp. 100067-100067
Open Access | Times Cited: 15
The roles of T cells in psoriasis
Peng Zhang, Yuwen Su, Siying Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasis
Yuhsien Lai, Xuesong Wu, Zhuoyu Jiang, et al.
Bioactive Materials (2024) Vol. 41, pp. 83-95
Open Access | Times Cited: 5
An Approach for Psoriasis of Microneedle Patch Simultaneously Targeting Multiple Inflammatory Cytokines and Relapse Related T Cells
Li Huang, Ying Luo, Le Kuai, et al.
Biomaterials (2025), pp. 123120-123120
Closed Access
The Role of Fibroblasts in Chronic Inflammatory and Proliferative Skin Diseases
Rui Zang, C. Xu, Fan Zhu, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 2
Closed Access
CCL27 is a crucial regulator of immune homeostasis of the skin and mucosal tissues
Micha L. Davila, Ming Xu, Chenyu Huang, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104426-104426
Open Access | Times Cited: 17
Self-assembled hyaluronic acid nanoparticles for the topical treatment of inflammatory skin diseases: Beyond drug carriers
Wang‐Hee Lee, Wook Kim
Journal of Controlled Release (2023) Vol. 366, pp. 114-127
Closed Access | Times Cited: 10
Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells
Li Zhang, Xia Li, Xintian Xu, et al.
Journal of the American Academy of Dermatology (2024) Vol. 90, Iss. 5, pp. 970-976
Open Access | Times Cited: 3
Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis
Theresa Benezeder, Natalie Bordag, Johannes Nikolaus Woltsche, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 3
Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis
Margaret H. Chang, Robert C. Fuhlbrigge, Peter A. Nigrović
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 5, pp. 258-271
Open Access | Times Cited: 3
Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions?
Immacolata Pietraforte, Loredana Frasca
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4348-4348
Open Access | Times Cited: 8
Could Targeted Pharmacotherapies Exert a “Disease Modification Effect” in Patients with Chronic Plaque Psoriasis?
Francesco Bellinato, Andrea Chiricozzi, Stefano Piaserico, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12849-12849
Open Access | Times Cited: 13
The genesis of cardiovascular risk in inflammatory arthritis: insights into glycocalyx shedding, endothelial dysfunction, and atherosclerosis initiation
Alexander Krasimirov Angelov, Miroslav Markov, Mariana Ivanova, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 10, pp. 2541-2555
Closed Access | Times Cited: 7
Geniposide alleviates imiquimod-induced psoriasis-like skin lesions in mice via inhibition of angiogenesis
Jiaojiao Chen, Yuan Liu, Nina Yin, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111923-111923
Closed Access | Times Cited: 2
Adjunctive Chinese medicine therapy reduces relapse of psoriasis vulgaris after discontinuation of biologics: a prospective registry-based cohort study
Shan Huang, Xingwu Duan, H Zhang, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Comorbidities among adult patients with psoriasis in Tianjin: a cross-sectional analysis of the Health Database study
Yiming Zhang, Yali Guo, Kaiyue Zhang, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e083683-e083683
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top